Tourmaline Bio, Inc. - Common Stock (NQ:TRML)
All News about Tourmaline Bio, Inc. - Common Stock
From Avalo Therapeutics
Via GlobeNewswire
Tourmaline Bio Announces Pricing of Public Offering of Common Stock
January 25, 2024
From Tourmaline Bio, Inc.
Via GlobeNewswire
Tourmaline Bio Announces Proposed Public Offering of Common Stock
January 24, 2024
From Tourmaline Bio, Inc.
Via GlobeNewswire
From Tourmaline Bio, Inc.
Via GlobeNewswire
Tourmaline Bio added to the NASDAQ Biotechnology Index
December 15, 2023
From Tourmaline Bio, Inc.
Via GlobeNewswire
Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board
December 14, 2023
From Tourmaline Bio, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.